Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Common Equity: 2014-2024

  • HUTCHMED (China)'s Common Equity rose 3.83% to $771.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $771.9 million, marking a year-over-year increase of 3.83%. This contributed to the annual value of $771.9 million for FY2024, which is 3.83% up from last year.
  • Per HUTCHMED (China)'s latest filing, its Common Equity stood at $771.9 million for Q4 2024, which was up 3.83% from $743.4 million recorded in Q4 2023.
  • HUTCHMED (China)'s Common Equity's 5-year high stood at $1.0 billion during Q4 2021, with a 5-year trough of $518.9 million in Q4 2020.
  • In the last 3 years, HUTCHMED (China)'s Common Equity had a median value of $743.4 million in 2023 and averaged $717.4 million.
  • Per our database at Business Quant, HUTCHMED (China)'s Common Equity spiked by 100.31% in 2021 and then plummeted by 38.73% in 2022.
  • Over the past 5 years, HUTCHMED (China)'s Common Equity (Quarterly) stood at $518.9 million in 2020, then spiked by 100.31% to $1.0 billion in 2021, then slumped by 38.73% to $636.9 million in 2022, then climbed by 16.73% to $743.4 million in 2023, then climbed by 3.83% to $771.9 million in 2024.
  • Its Common Equity was $771.9 million in Q4 2024, compared to $743.4 million in Q4 2023 and $636.9 million in Q4 2022.